Literature DB >> 29539283

HIV-Associated Cancers and Related Diseases.

Robert Yarchoan1, Thomas S Uldrick1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29539283      PMCID： PMC6890231          DOI： 10.1056/NEJMra1615896

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  83 in total

Review 1.  Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis.

Authors:  Dorothy A Machalek; Mary Poynten; Fengyi Jin; Christopher K Fairley; Annabelle Farnsworth; Suzanne M Garland; Richard J Hillman; Kathy Petoumenos; Jennifer Roberts; Sepehr N Tabrizi; David J Templeton; Andrew E Grulich
Journal:  Lancet Oncol       Date:  2012-03-23       Impact factor: 41.316

2.  Cancer burden in the HIV-infected population in the United States.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; Mitchell H Gail; H Irene Hall; Jianmin Li; Anil K Chaturvedi; Kishor Bhatia; Thomas S Uldrick; Robert Yarchoan; James J Goedert; Eric A Engels
Journal:  J Natl Cancer Inst       Date:  2011-04-11       Impact factor: 13.506

Review 3.  Use of antineoplastic agents in patients with cancer who have HIV/AIDS.

Authors:  Michelle A Rudek; Charles Flexner; Richard F Ambinder
Journal:  Lancet Oncol       Date:  2011-05-12       Impact factor: 41.316

4.  HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era.

Authors:  Rita Coutinho; Alessia D Pria; Shreyans Gandhi; Katharine Bailey; Paul Fields; Kate Cwynarski; Andrew Wilson; Panagiotis Papanastasopoulos; Melinda Tenant-Flowers; Andrew Webb; Fiona Burns; Robert E Marcus; Chloe Orkin; Silvia Montoto; Mark Bower
Journal:  AIDS       Date:  2014-03-13       Impact factor: 4.177

5.  How I treat HIV-associated multicentric Castleman disease.

Authors:  Mark Bower
Journal:  Blood       Date:  2010-08-05       Impact factor: 22.113

6.  Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.

Authors:  Michael J Silverberg; Bryan Lau; Chad J Achenbach; Yuezhou Jing; Keri N Althoff; Gypsyamber D'Souza; Eric A Engels; Nancy A Hessol; John T Brooks; Ann N Burchell; M John Gill; James J Goedert; Robert Hogg; Michael A Horberg; Gregory D Kirk; Mari M Kitahata; Philip T Korthuis; William C Mathews; Angel Mayor; Sharada P Modur; Sonia Napravnik; Richard M Novak; Pragna Patel; Anita R Rachlis; Timothy R Sterling; James H Willig; Amy C Justice; Richard D Moore; Robert Dubrow
Journal:  Ann Intern Med       Date:  2015-10-06       Impact factor: 25.391

7.  Epstein-Barr virus in AIDS-related primary central nervous system lymphoma.

Authors:  E M MacMahon; J D Glass; S D Hayward; R B Mann; P S Becker; P Charache; J C McArthur; R F Ambinder
Journal:  Lancet       Date:  1991-10-19       Impact factor: 79.321

Review 8.  How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.

Authors:  Thomas S Uldrick; Richard F Little
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

9.  Human papilloma virus prevalence in HIV patients with head and neck squamous cell carcinoma.

Authors:  Annabelle Picard; Cécile Badoual; Muriel Hourseau; Caroline Halimi; Hélène Pere; Fadia Dib; Béatrix Barry; Sébastien Albert
Journal:  AIDS       Date:  2016-05-15       Impact factor: 4.177

10.  Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma.

Authors:  Renan Duprez; Vincent Lacoste; Josette Brière; Pierre Couppié; Camille Frances; Dominique Sainte-Marie; Eric Kassa-Kelembho; Marie-Jeanne Lando; Jean-Louis Essame Oyono; Blaise Nkegoum; Oumkaltoum Hbid; Antoine Mahé; Céleste Lebbé; Patricia Tortevoye; Michel Huerre; Antoine Gessain
Journal:  J Natl Cancer Inst       Date:  2007-07-10       Impact factor: 13.506
View more
  90 in total

1.  HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient's care behalf the CANCERVIH Group.

Authors:  Aurelien Gobert; Jean-Philippe Spano; Jacques Cadranel
Journal:  Med Oncol       Date:  2018-12-05       Impact factor: 3.064

2.  Gabapentin and Cancer Risk: Updated Findings from Kaiser Permanente Northern California.

Authors:  Gary D Friedman; Ninah Achacoso; Laurel A Habel
Journal:  Perm J       Date:  2019

Review 3.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

4.  EphA7 Functions as Receptor on BJAB Cells for Cell-to-Cell Transmission of the Kaposi's Sarcoma-Associated Herpesvirus and for Cell-Free Infection by the Related Rhesus Monkey Rhadinovirus.

Authors:  Anna K Großkopf; Sarah Schlagowski; Bojan F Hörnich; Thomas Fricke; Ronald C Desrosiers; Alexander S Hahn
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

5.  A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma.

Authors:  Ramya Ramaswami; Thomas S Uldrick; Mark N Polizzotto; Kathleen M Wyvill; Priscila Goncalves; Anaida Widell; Kathryn Lurain; Seth M Steinberg; William Douglas Figg; Giovanna Tosato; Denise Whitby; Robert Yarchoan
Journal:  Clin Cancer Res       Date:  2019-04-12       Impact factor: 12.531

6.  Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Authors:  Ramya Ramaswami; Kathryn Lurain; Cody J Peer; Anna Serquiña; Victoria Wang; Anaida Widell; Priscila Goncalves; Seth M Steinberg; Vickie Marshall; Jomy George; William D Figg; Denise Whitby; Joseph Ziegelbauer; Thomas S Uldrick; Robert Yarchoan
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

Review 7.  Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer.

Authors:  Kathryn Lurain; Ramya Ramaswami; Robert Yarchoan; Thomas S Uldrick
Journal:  Curr HIV/AIDS Rep       Date:  2020-10       Impact factor: 5.071

8.  Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.

Authors:  Victoria Wang; David A Davis; Claire Deleage; Catherine Brands; Hong S Choi; Muzammel Haque; Robert Yarchoan
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

9.  Multiple remissions of extracavitary primary effusion lymphoma treated with a single cycle of liposomal doxorubicin in a patient infected with HIV.

Authors:  J Chen; V Mehraj; J Szabo; B Routy; R P Michel; J P Routy
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

Review 10.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.